In end-stage lung diseases, the shortage of donor lungs for transplantation and long waiting lists are the main culprits in the significantly increasing number of patient deaths. New strategies to curb this issue are being developed with the help of recent advancements in bioengineering technology, with the generation of lung scaffolds as a steppingstone. There are various types of lung scaffolds, namely, acellular scaffolds that are developed via decellularization and recellularization techniques, artificial scaffolds that are synthesized using synthetic, biodegradable, and low immunogenic materials, and hybrid scaffolds which combine the advantageous properties of materials in the development of a desirable lung scaffold. There have also ...
Destructive respiratory diseases are predicted to become the 3rd global cause of morbidity and morta...
Lung diseases are a leading cause of death worldwide. Due to a lack of knowledge of the underlying p...
Stem cell technologies, especially patient-specific, induced stem cell pluripotency and directed dif...
In end-stage lung diseases, the shortage of donor lungs for transplantation and long waiting lists a...
Chronic respiratory diseases remain a major cause of morbidity and mortality worldwide. The only opt...
Chronic respiratory diseases remain a major cause of morbidity and mortality worldwide. The only opt...
For patients with end-stage lung diseases, lung transplantation is the only available therapeutic op...
Lung diseases can be classified as Chronic Obstructive Pulmonary Disorder (COPD), pulmonary fibrosis...
Recent advances in whole lung bioengineering have opened new doors for studying lung repair and rege...
The number of deaths around the globe due to lung diseases is over 9.5 million each year, including ...
Lung disease is the third leading cause of death worldwide. The shortage of transplantable donor org...
The limited available treatment options for patients with chronic lung diseases, such as fibrosis, l...
A current approach to obtain bioengineered lungs as a future alternative for transplantation is base...
Lung transplantation may be a final destination therapy in lung failure, but limited donor organ ava...
Currently, lung disease and major airway trauma constitute a major global healthcare burden with lim...
Destructive respiratory diseases are predicted to become the 3rd global cause of morbidity and morta...
Lung diseases are a leading cause of death worldwide. Due to a lack of knowledge of the underlying p...
Stem cell technologies, especially patient-specific, induced stem cell pluripotency and directed dif...
In end-stage lung diseases, the shortage of donor lungs for transplantation and long waiting lists a...
Chronic respiratory diseases remain a major cause of morbidity and mortality worldwide. The only opt...
Chronic respiratory diseases remain a major cause of morbidity and mortality worldwide. The only opt...
For patients with end-stage lung diseases, lung transplantation is the only available therapeutic op...
Lung diseases can be classified as Chronic Obstructive Pulmonary Disorder (COPD), pulmonary fibrosis...
Recent advances in whole lung bioengineering have opened new doors for studying lung repair and rege...
The number of deaths around the globe due to lung diseases is over 9.5 million each year, including ...
Lung disease is the third leading cause of death worldwide. The shortage of transplantable donor org...
The limited available treatment options for patients with chronic lung diseases, such as fibrosis, l...
A current approach to obtain bioengineered lungs as a future alternative for transplantation is base...
Lung transplantation may be a final destination therapy in lung failure, but limited donor organ ava...
Currently, lung disease and major airway trauma constitute a major global healthcare burden with lim...
Destructive respiratory diseases are predicted to become the 3rd global cause of morbidity and morta...
Lung diseases are a leading cause of death worldwide. Due to a lack of knowledge of the underlying p...
Stem cell technologies, especially patient-specific, induced stem cell pluripotency and directed dif...